CANNULA, NASAL, OXYGE

The contract solicitation SPE2DS-26-T-064R is for the procurement of 50-unit packages of sterile, disposable, latex-free nasal oxygen cannulas, each featuring an 84-inch plastic polyvinyl chloride tube with a curved flared tip and standard connector in an over-the-ear design, intended for adult use. The item, identified by NSN 6515-01-480-2308 and classified under NAICS code 339112, must comply with stringent technical and quality requirements outlined in the DLA Master List of Technical and Quality Requirements, including adherence to Medical Marking Standard No. 1, which replaces MIL-STD-129 for all medical items. Packaging must conform to MIL-STD-2073-1E with commercial packaging standards applied, and each unit must be sealed in protective containers for safe transport via common carrier. Shelf life is strictly regulated with a maximum of 60 months and no more than nine months allowed to have elapsed from manufacture to government delivery. The product is regulated by the FDA, requiring referral to a product specialist for vendor confirmation and compliance verification. Delivery is required FOB destination within 84 days of order placement to a military medical logistics facility in Korea, with inspection and acceptance occurring at the destination. The contract applies a 0% quantity variance and mandates electronic invoicing through Wide Area WorkFlow. The Defense Logistics Agency, through its Medical Supply Chain division, is the procuring entity, with Allen Costello designated as the primary point of contact. Compliance with multiple Federal Acquisition Regulation clauses is required including those addressing contractor cybersecurity (252.204-7012), hazardous materials labeling (252.223-7001), employment eligibility verification, sustainable products, and safeguarding defense information. The solicitation references multiple eligible vendors including Cardinal Health, Teleflex, and Medline Industries, and requires bidders to specify source and part number. While the contract type and pricing are not explicitly filled in, the structure suggests a simplified acquisition likely conducted on a lowest price technically acceptable basis, using DIBBS for submission, and includes no options, modifications, or special personnel requirements beyond general regulatory compliance.